Neurotechnology Group is part of a new SNSF Sinergia Grant
International consortium receives funding from the Swiss National Science Foundation (SNSF) for precision medicine in pediatric brain tumors
SNSF Sinergia grant awarded to identify novel treatment strategies for children with aggressive brain tumors.
An international and multi-disciplinary team of researchers, clinicians, and data scientists, led by Dr. Nazarian, aims to improve treatment for children with aggressive brain tumors has been awarded a Sinergia grant from the Swiss National Science Foundation (SNSF). The new Sinergia consortium incorporates the ETH Neurotechnology Group and in Children's Hospital in Zurich and a group in Norway and has received CHF 3.1 million for their interdisciplinary and collaborative research project on harnessing novel technologies for precision medicine in pediatric diffuse midline glioma.
More information @ https://www.med.uio.no/ncmm/english/news-and-events/news/2020/international-consortium-receives-funding-from-the.html